⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Official Title: High-dose Testosterone in Men With Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 Deficiency

Study ID: NCT05011383

Study Description

Brief Summary: This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically unstable because of DNA repair deficiency and this is a prospective study to test that hypothesis

Detailed Description: This is an unblinded, three cohort phase II study evaluating the efficacy of high dose testosterone (BAT) for patients with mCRPC and inactivating mutations in ATM, CDK12 or CHEK2. Patients will receive BAT until disease progression or intolerance, whichever occurs first. Throughout the study, safety and tolerability will be assessed by frequent recording of adverse events, vital signs and safety laboratory assessments. Progression will be evaluated with bone scan, CT of the abdomen/pelvis and PSA as per PCWG3 criteria.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States

VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States

Orlando VA Medical Center, Orlando, FL, Orlando, Florida, United States

Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States

Robley Rex VA Medical Center, Louisville, KY, Louisville, Kentucky, United States

Kansas City VA Medical Center, Kansas City, MO, Kansas City, Missouri, United States

St. Louis VA Medical Center John Cochran Division, St. Louis, MO, Saint Louis, Missouri, United States

Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States

Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury, North Carolina, United States

VA Portland Health Care System, Portland, OR, Portland, Oregon, United States

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States

Memphis VA Medical Center, Memphis, TN, Memphis, Tennessee, United States

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville, Tennessee, United States

Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States

Contact Details

Name: Robert B. Montgomery, MD

Affiliation: VA Puget Sound Health Care System Seattle Division, Seattle, WA

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: